AKT1 and myelodysplastic syndrome: In summary, IGF signaling interacts with multiple oncogenic pathways, including PI3K/Akt/mTOR, Ras/Raf/MEK/ERK, Wnt/β-catenin, and Hedgehog, collectively driving MDS and AML progression.